Today: 13 June 2026

Shan Ahmed Khan

As a journalist focused on finance and the stock market, he delivers fast, reliable, and easy-to-understand coverage of market news.

Kymera Therapeutics stock extends slide as KYMR closes down 6.5% — what investors watch next

Kymera Therapeutics stock extends slide as KYMR closes down 6.5% — what investors watch next

Kymera Therapeutics shares fell 6.5% to $72.76 on Friday, marking a seventh straight daily loss and leaving the stock down 29% from its early December peak. About 854,000 shares traded as investors shifted focus to 2026 trial milestones and funding. CEO Nello Mainolfi sold 30,000 shares in a pre-arranged plan on Dec. 31. The company raised $602 million in a December stock offering at $86 per share.
4 January 2026
·
Guidewire Software stock slides 6.7% into weekend; what GWRE investors watch next

Guidewire Software stock slides 6.7% into weekend; what GWRE investors watch next

Guidewire Software shares fell 6.7% to $187.63 on Friday, closing below key moving averages after a quiet news period. The stock’s 14-day RSI neared 30, signaling oversold conditions, as investors awaited U.S. jobs data and Guidewire’s next earnings in March. About 806,660 shares traded in a session marked by light volume. Guidewire last reported Q1 revenue of $332.6 million and raised its fiscal-year outlook in December.
4 January 2026
·
BILL stock slides 7% to start 2026 despite KBW target raise — what to watch Monday

BILL stock slides 7% to start 2026 despite KBW target raise — what to watch Monday

BILL Holdings shares fell 7.3% to $50.56 Friday, marking one of their steepest single-day drops in weeks. Keefe, Bruyette & Woods raised its price target to $60 but maintained a “market perform” rating. The decline came as the S&P 500 rose 0.19% and the Nasdaq was flat. BILL’s next key events include a Jan. 16 finance leadership change and an earnings update expected in early February.
4 January 2026
··
TeraWulf (WULF) stock jumps nearly 11% as bitcoin miners rally — what traders watch next

TeraWulf (WULF) stock jumps nearly 11% as bitcoin miners rally — what traders watch next

TeraWulf shares jumped 10.8% to $12.74 Friday, outpacing bitcoin’s 1.4% rise. Insider filings showed CEO Paul Prager and other top executives received millions of new equity awards. Two directors reported share grants in lieu of cash retainers. The moves come as TeraWulf expands into data-center hosting and secures $1.3 billion in project financing.
4 January 2026
···
NexGen Energy stock jumps 11%: the next dates that matter for NXE

NexGen Energy stock jumps 11%: the next dates that matter for NXE

NexGen Energy’s U.S. shares jumped 11.4% to $10.25 Friday, with volume tripling to 13.1 million after Denison Mines announced readiness to launch its Phoenix uranium project. The rally pushed NexGen to a 52-week high. Attention now shifts to a January 9 intervention deadline and a February licensing hearing for NexGen’s Rook I project before Canadian regulators.
4 January 2026
·
Hut 8 stock jumps 12% to start 2026 as Coinbase boosts bitcoin-backed credit line — what to watch next

Hut 8 stock jumps 12% to start 2026 as Coinbase boosts bitcoin-backed credit line — what to watch next

Hut 8 shares jumped 11.6% to $51.27 Friday after the company increased its bitcoin-backed credit facility with Coinbase to $200 million and drew the full amount. The stock traded between $46.83 and $52.61, with about 6.5 million shares changing hands. Other crypto miners also rallied as bitcoin rose 1.5% to $91,286. Hut 8 plans to use the loan proceeds for general corporate purposes.
4 January 2026
····
CoreWeave stock jumps 11% on credit-covenant relief — what CRWV investors watch next

CoreWeave stock jumps 11% on credit-covenant relief — what CRWV investors watch next

CoreWeave shares closed up 10.8% at $79.32 Friday after an SEC filing showed the AI cloud firm eased near-term liquidity rules and delayed lender covenant tests on a key loan. The amendment lowered required cash reserves to $100 million for March–April 2026 and pushed the first debt service coverage test to October 2027. Insider stock sales disclosed were mainly for tax withholding on vested awards. Trading volume topped 30 million shares.
4 January 2026
1 … 314 315 316 317 318 … 590

Stock Market Today

  • ChronoScale Stock Soars Amid High Valuation and Losses
    June 13, 2026, 2:14 PM EDT. ChronoScale (CHRN) shares surged 134.18% year-to-date, delivering a 378.12% total return over one year despite a $72.73 million loss on $84.38 million revenue. The Dallas-based AI compute platform's stock trades at a striking price-to-sales (P/S) ratio of 31.3x, far above the US IT sector average of 1.7x and peers at 2.3x. This elevated P/S indicates strong investor expectations for future revenue growth and profitability, though it raises risks if the company fails to meet these projections. Investors are advised to weigh these factors carefully and consider broader AI infrastructure opportunities. The sharp ascent and stretched valuation suggest volatility ahead, making due diligence crucial.

Latest articles

FINRA hits Merrill Lynch with $225,000 fine for 1,600 missed customer complaints

FINRA hits Merrill Lynch with $225,000 fine for 1,600 missed customer complaints

13 June 2026
FINRA fined Merrill Lynch $225,000 and issued a censure after finding the firm failed to report over 1,600 customer complaints from post-call surveys in 2023, citing inadequate supervisory review and violation of reporting rules; Merrill self-disclosed, conducted a lookback, resolved complaints, and suspended written survey comments in January 2024.
Starbucks Stock Price Nears 52-Week High as Turnaround Rally Faces a Valuation Test

Starbucks Stock Price Nears 52-Week High as Turnaround Rally Faces a Valuation Test

13 June 2026
Starbucks closed Friday at $103.04, up 0.74% and just 5% below its 52-week high, as investors await fiscal Q3 results to see if strong traffic can keep offsetting labor and coffee-cost pressure; management recently raised 2026 guidance after reporting 6.2% global comp sales growth and a 9% revenue jump in Q2, but margin declines and a high P/E ratio leave little room for disappointment.
Go toTop